Variant report

Variant	nsv553872
Chromosome Location	chr11:25586656-25625889
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:78)
CpG islands
(count:61)
Chromatin interactive
region (count:1)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:78 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr11:25623762-25623935	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr11:25588146-25588479	HepG2	liver:	n/a	n/a
3	CEBPB	chr11:25607889-25608194	HepG2	liver:	n/a	n/a
4	CEBPB	chr11:25588189-25588366	HepG2	liver:	n/a	n/a
5	CEBPB	chr11:25588119-25588837	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr11:25588263-25588319	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr11:25623780-25623930	HPF	lung:	n/a	n/a
8	CTCF	chr11:25606859-25606882	GM20000	blood:	n/a	n/a
9	CTCF	chr11:25606896-25606899	GM20000	blood:	n/a	n/a
10	E2F4	chr11:25616132-25616392	MCF10A-Er-Src	breast:	n/a	n/a
11	EP300	chr11:25614816-25615134	SK-N-SH_RA	brain:	n/a	n/a
12	EP300	chr11:25588134-25588529	Hela-S3	cervix:	n/a	n/a
13	FOS	chr11:25618279-25618545	MCF10A-Er-Src	breast:	n/a	n/a
14	FOS	chr11:25609170-25609433	MCF10A-Er-Src	breast:	n/a	chr11:25609317-25609326 chr11:25609317-25609325 chr11:25609318-25609325 chr11:25609316-25609326
15	FOS	chr11:25618316-25618516	MCF10A-Er-Src	breast:	n/a	n/a
16	FOS	chr11:25588215-25588423	MCF10A-Er-Src	breast:	n/a	n/a
17	FOS	chr11:25609155-25609369	MCF10A-Er-Src	breast:	n/a	chr11:25609317-25609326 chr11:25609317-25609325 chr11:25609318-25609325 chr11:25609316-25609326
18	FOS	chr11:25618375-25618587	MCF10A-Er-Src	breast:	n/a	n/a
19	GATA2	chr11:25616883-25617244	SH-SY5Y	brain:	n/a	n/a
20	GATA3	chr11:25617089-25617252	SH-SY5Y	brain:	n/a	n/a
21	GATA3	chr11:25615099-25615162	SH-SY5Y	brain:	n/a	n/a
22	JUN	chr11:25623924-25623969	H1-hESC	embryonic stem cell:	n/a	n/a
23	JUND	chr11:25618424-25618457	H1-hESC	embryonic stem cell:	n/a	n/a
24	JUND	chr11:25623841-25624041	H1-hESC	embryonic stem cell:	n/a	n/a
25	MAFF	chr11:25625677-25625793	HepG2	liver:	n/a	n/a
26	MAFF	chr11:25607532-25607858	HepG2	liver:	n/a	chr11:25607677-25607695
27	MAFF	chr11:25607548-25607819	K562	blood:	n/a	chr11:25607677-25607695
28	MAFK	chr11:25622010-25622185	HepG2	liver:	n/a	chr11:25622059-25622074
29	MAFK	chr11:25625602-25625874	HepG2	liver:	n/a	chr11:25625699-25625710 chr11:25625688-25625705
30	MAFK	chr11:25625682-25625872	HepG2	liver:	n/a	chr11:25625699-25625710 chr11:25625688-25625705
31	MAFK	chr11:25621890-25621907	HepG2	liver:	n/a	n/a
32	MAFK	chr11:25607593-25607839	HepG2	liver:	n/a	n/a
33	MAFK	chr11:25607529-25607826	IMR90	lung:	n/a	n/a
34	MAFK	chr11:25607531-25607866	HepG2	liver:	n/a	n/a
35	MAFK	chr11:25607623-25607757	K562	blood:	n/a	n/a
36	MAFK	chr11:25607619-25607709	Hela-S3	cervix:	n/a	n/a
37	MAZ	chr11:25620210-25620338	HepG2	liver:	n/a	n/a
38	MXI1	chr11:25624466-25624499	Hela-S3	cervix:	n/a	n/a
39	MYC	chr11:25588303-25588388	NB4	blood:	n/a	n/a
40	NANOG	chr11:25601191-25601372	H1-hESC	embryonic stem cell:	n/a	n/a
41	NFYA	chr11:25610902-25610992	GM12878	blood:	n/a	n/a
42	NFYA	chr11:25623677-25624156	Hela-S3	cervix:	n/a	n/a
43	NFYB	chr11:25623981-25624181	GM12878	blood:	n/a	n/a
44	POLR2A	chr11:25590135-25590223	MCF10A-Er-Src	breast:	n/a	n/a
45	POLR2A	chr11:25606601-25606604	MCF10A-Er-Src	breast:	n/a	n/a
46	POLR2A	chr11:25606521-25606657	MCF10A-Er-Src	breast:	n/a	n/a
47	POLR2A	chr11:25586608-25586703	MCF10A-Er-Src	breast:	n/a	n/a
48	POLR2A	chr11:25608872-25608893	MCF10A-Er-Src	breast:	n/a	n/a
49	POLR2A	chr11:25588286-25588451	MCF10A-Er-Src	breast:	n/a	n/a
50	POLR2A	chr11:25599635-25599713	MCF10A-Er-Src	breast:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:25623877-25623927	HRPEpiC	eye:	n/a
2	chr11:25623877-25623927	BE2_C	brain:	n/a
3	chr11:25623877-25623927	LNCaP	prostate:	n/a
4	chr11:25623877-25623927	Jurkat	blood:	n/a
5	chr11:25623877-25623927	HIPEpiC	eye:	n/a
6	chr11:25623877-25623927	GM19239	blood:	n/a
7	chr11:25623877-25623927	SK-N-SH_RA	brain:	n/a
8	chr11:25623877-25623927	T-47D	breast:	n/a
9	chr11:25623877-25623927	MCF-7	breast:	n/a
10	chr11:25623877-25623927	NHDF-neo	bronchial:	n/a
11	chr11:25623877-25623927	PANC-1	pancreas:	n/a
12	chr11:25623877-25623927	BJ	skin:	n/a
13	chr11:25623877-25623927	NH-A	brain:	n/a
14	chr11:25623877-25623927	AG09319	gingival:	n/a
15	chr11:25623877-25623927	HCT-116	colon:	n/a
16	chr11:25623877-25623927	HCPEpiC	choroid plexus:	n/a
17	chr11:25623877-25623927	AG04449	skin:	fetal
18	chr11:25623877-25623927	PrEC	prostate:	n/a
19	chr11:25623877-25623927	SK-N-SH	brain:	n/a
20	chr11:25623877-25623927	PFSK-1	brain:	n/a
21	chr11:25623877-25623927	SAEC	small airway:	n/a
22	chr11:25623877-25623927	SK-N-MC	brain:	n/a
23	chr11:25623877-25623927	HCF	heart:	n/a
24	chr11:25623877-25623927	RPTEC	kidney:	n/a
25	chr11:25623877-25623927	HPAEpiC	pulmonary alveolar:	n/a
26	chr11:25623877-25623927	ECC-1	luminal epithelium:	n/a
27	chr11:25623877-25623927	HEEpiC	esophagus:	n/a
28	chr11:25623877-25623927	NT2-D1	testis:	n/a
29	chr11:25623877-25623927	HEK293	kidney:	embryo
30	chr11:25623877-25623927	HUVEC	blood vessel:	n/a
31	chr11:25623877-25623927	CMK	blood:	n/a
32	chr11:25623877-25623927	A549	lung:	n/a
33	chr11:25623877-25623927	ProgFib	skin:	n/a
34	chr11:25623877-25623927	HCM	heart:	n/a
35	chr11:25623877-25623927	H1-hESC	embryonic stem cell:	embryo
36	chr11:25623877-25623927	NHBE	bronchial:	n/a
37	chr11:25623877-25623927	HRE	kidney:	n/a
38	chr11:25623877-25623927	HAEpiC	amniotic membrane:	n/a
39	chr11:25623877-25623927	HL-60	blood:	n/a
40	chr11:25623877-25623927	IMR90	lung:	fetal
41	chr11:25623877-25623927	Hela-S3	cervix:	n/a
42	chr11:25623877-25623927	ovcar-3	ovarian:	n/a
43	chr11:25623877-25623927	HRCEpiC	kidney:	n/a
44	chr11:25623877-25623927	Caco-2	colon:	n/a
45	chr11:25623877-25623927	HMEC	breast:	n/a
46	chr11:25623877-25623927	AoSMC	blood vessel:	n/a
47	chr11:25623877-25623927	GM12878	blood:	n/a
48	chr11:25623877-25623927	HNPCEpiC	eye:	n/a
49	chr11:25623877-25623927	MCF10A-Er-Src	breast:	n/a
50	chr11:25623877-25623927	K562	blood:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:25619794..25621822-chr11:25698109..25699950,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-MUC15-3	chr11:25610021-25610341	NONHSAT018448
2	lnc-MUC15-3	chr11:25610021-25610389	NONHSAT018447
3	lnc-MUC15-3	chr11:25609916-25610413	NONHSAT018446
4	lnc-MUC15-3	chr11:25609802-25609808	NONHSAT018446

No data

Variant related genes	Relation type
RPL36AP40	TF binding region
RPL36AP40	CpG island

Extended variants
information (count: 1384 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:1384 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10501015	chr11:25586656-25586657	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs532522676	chr11:25586681-25586682	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs141406911	chr11:25586685-25586686	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs554179677	chr11:25586686-25586687	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs572753863	chr11:25586798-25586799	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs539871696	chr11:25586800-25586801	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs534104681	chr11:25586819-25586820	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs551007900	chr11:25586844-25586845	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs138685370	chr11:25586874-25586875	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs573386517	chr11:25586970-25586971	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs372717103	chr11:25586972-25586973	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs543931864	chr11:25586973-25586974	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs367913300	chr11:25586974-25586975	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs142061583	chr11:25587002-25587003	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs201367427	chr11:25587022-25587023	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs550241108	chr11:25587023-25587024	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs397849791	chr11:25587038-25587039	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs545240157	chr11:25587041-25587042	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs377673985	chr11:25587051-25587052	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs560208846	chr11:25587146-25587147	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs527650885	chr11:25587153-25587154	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs191565932	chr11:25587202-25587203	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs567689597	chr11:25587220-25587221	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs531836938	chr11:25587364-25587365	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs550336387	chr11:25587368-25587369	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs11827440	chr11:25587378-25587379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs530161221	chr11:25587383-25587384	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs72247085	chr11:25587402-25587403	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs58940274	chr11:25587405-25587406	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs529499021	chr11:25587442-25587443	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs57130831	chr11:25587455-25587456	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs538865231	chr11:25587465-25587466	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs554421469	chr11:25587496-25587497	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs372661246	chr11:25587498-25587499	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs375809409	chr11:25587513-25587514	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs79909074	chr11:25587519-25587520	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs112826129	chr11:25587622-25587623	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs573350002	chr11:25587662-25587663	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs183670998	chr11:25587680-25587681	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs141735113	chr11:25587700-25587701	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs146286604	chr11:25587728-25587729	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs534901236	chr11:25587828-25587829	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs79199411	chr11:25587875-25587876	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs544891265	chr11:25587896-25587897	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs148476016	chr11:25587925-25587926	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs572221962	chr11:25587961-25587962	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs542952767	chr11:25588003-25588004	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs561254892	chr11:25588014-25588015	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs531745915	chr11:25588034-25588035	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs141647919	chr11:25588076-25588077	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Multiple myeloma	16461302	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Medulloblastoma	16783165	CNVD
small cell lung cancer	20016488	CNVD
Congenital diaphragmatic hernia	21525063	CNVD
Renal cell carcinoma	18194544	CNVD
Myelofibrosis	22110671	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
Chordoma	18071362	CNVD
Autism	22102821	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21364760	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:102 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:25581800-25587800	Weak transcription	NHEK	skin
2	chr11:25585000-25586800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr11:25586400-25591200	Enhancers	Breast Myoepithelial Primary Cells	Breast
4	chr11:25586800-25587000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr11:25586800-25589600	Enhancers	HMEC	breast
6	chr11:25587000-25587400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
7	chr11:25587400-25589000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr11:25587600-25588600	Enhancers	Ovary	ovary
9	chr11:25587600-25589000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr11:25587600-25589400	Enhancers	Dnd41	blood
11	chr11:25587600-25589400	Enhancers	Hela-S3	cervix
12	chr11:25587800-25589000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
13	chr11:25587800-25589200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr11:25587800-25589200	Enhancers	NHEK	skin
15	chr11:25587800-25590400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr11:25590400-25598000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
17	chr11:25591200-25592400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
18	chr11:25592400-25592800	Enhancers	Breast Myoepithelial Primary Cells	Breast
19	chr11:25592800-25599200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
20	chr11:25596600-25599600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr11:25596600-25600000	Enhancers	NHEK	skin
22	chr11:25597200-25599600	Enhancers	HMEC	breast
23	chr11:25598000-25599600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
24	chr11:25598000-25603000	Enhancers	ES-I3 Cell Line	embryonic stem cell
25	chr11:25598200-25600600	Enhancers	HUES64 Cell Line	embryonic stem cell
26	chr11:25598800-25599800	Enhancers	HUES6 Cell Line	embryonic stem cell
27	chr11:25598800-25599800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr11:25598800-25600800	Enhancers	HUES48 Cell Line	embryonic stem cell
29	chr11:25598800-25600800	Enhancers	iPS-20b Cell Line	embryonic stem cell
30	chr11:25598800-25601200	Enhancers	iPS-15b Cell Line	embryonic stem cell
31	chr11:25599200-25599400	Enhancers	Breast Myoepithelial Primary Cells	Breast
32	chr11:25599200-25600600	Enhancers	iPS-18 Cell Line	embryonic stem cell
33	chr11:25599400-25599600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr11:25599400-25599600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
35	chr11:25599400-25601800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
36	chr11:25599600-25601800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
37	chr11:25599600-25608600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
38	chr11:25599800-25600200	Weak transcription	HUES6 Cell Line	embryonic stem cell
39	chr11:25600200-25600600	Enhancers	HUES6 Cell Line	embryonic stem cell
40	chr11:25600600-25601000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
41	chr11:25600600-25601000	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
42	chr11:25600600-25601000	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
43	chr11:25600600-25601400	Enhancers	H9 Cell Line	embryonic stem cell
44	chr11:25600800-25601000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
45	chr11:25600800-25601000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
46	chr11:25600800-25602200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
47	chr11:25601000-25601200	Enhancers	HUES48 Cell Line	embryonic stem cell
48	chr11:25601000-25601200	Enhancers	HUES6 Cell Line	embryonic stem cell
49	chr11:25601000-25601200	Enhancers	HUES64 Cell Line	embryonic stem cell
50	chr11:25601000-25601200	Enhancers	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links